These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 29542417)

  • 1. Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients.
    Peluso R; Caso F; Tasso M; Ambrosino P; Dario Di Minno MN; Lupoli R; Criscuolo L; Caso P; Ursini F; Puente AD; Scarpa R; Costa On Behalf Of CaRRDs Study Group L
    Rev Recent Clin Trials; 2018; 13(3):199-209. PubMed ID: 29542417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis.
    Peluso R; Caso F; Tasso M; Sabbatino V; Lupoli R; Dario Di Minno MN; Ursini F; Costa L; Scarpa R
    Open Access Rheumatol; 2019; 11():143-156. PubMed ID: 31388317
    [No Abstract]   [Full Text] [Related]  

  • 3. Endothelial dysfunction and the effects of TNF inhibitors on the endothelium in psoriasis and psoriatic arthritis: a systematic review.
    Brezinski EA; Follansbee MR; Armstrong EJ; Armstrong AW
    Curr Pharm Des; 2014; 20(4):513-28. PubMed ID: 23565632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular risk markers in patients with psoriatic arthritis: A meta-analysis of literature studies.
    Di Minno MN; Ambrosino P; Lupoli R; Di Minno A; Tasso M; Peluso R; Tremoli E
    Ann Med; 2015 Jun; 47(4):346-53. PubMed ID: 25953378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review.
    Jamnitski A; Symmons D; Peters MJ; Sattar N; McInnes I; Nurmohamed MT
    Ann Rheum Dis; 2013 Feb; 72(2):211-6. PubMed ID: 22532629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review.
    Horreau C; Pouplard C; Brenaut E; Barnetche T; Misery L; Cribier B; Jullien D; Aractingi S; Aubin F; Joly P; Le Maître M; Ortonne JP; Paul C; Richard MA
    J Eur Acad Dermatol Venereol; 2013 Aug; 27 Suppl 3():12-29. PubMed ID: 23845149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between metabolic syndrome and carotid intima-media thickness: cross-sectional comparison between psoriasis and psoriatic arthritis.
    Lin YC; Dalal D; Churton S; Brennan DM; Korman NJ; Kim ES; Husni ME
    Arthritis Care Res (Hoboken); 2014 Jan; 66(1):97-103. PubMed ID: 23983044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of subclinical atherosclerosis in psoriatic arthritis patients with minimal disease activity.
    Yilmazer B; Sahin T; Unlu BÖ; Kir HM; Cefle A
    Rheumatol Int; 2015 Aug; 35(8):1385-92. PubMed ID: 25669439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of biologic agents and other disease-modifying antirheumatic drugs on cardiovascular outcomes in psoriasis and psoriatic arthritis: a systematic review.
    Armstrong AW; Brezinski EA; Follansbee MR; Armstrong EJ
    Curr Pharm Des; 2014; 20(4):500-12. PubMed ID: 23565631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclinical impairment of myocardial and endothelial functionality in very early psoriatic and rheumatoid arthritis patients: Association with vitamin D and inflammation.
    Lo Gullo A; Rodríguez-Carrio J; Aragona CO; Dattilo G; Zito C; Suárez A; Loddo S; Atteritano M; Saitta A; Mandraffino G
    Atherosclerosis; 2018 Apr; 271():214-222. PubMed ID: 29524864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriasis: a skin disease associated with increased cardiovascular risk.
    González-Gay MA; González-Vela C; González-Juanatey C
    Actas Dermosifiliogr; 2012 Sep; 103(7):595-8. PubMed ID: 22465257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Extent of Subclinical Atherosclerosis and Associated Cardiovascular Risk Factors in Adult Patients With Psoriatic Arthritis: A Systematic Review.
    Jamil M; Aslam R; Patel A; Nadir B; Khan S
    Cureus; 2021 Aug; 13(8):e16853. PubMed ID: 34513433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk reclassification according to six cardiovascular risk algorithms and carotid ultrasound in psoriatic arthritis patients.
    Galarza-Delgado DA; Azpiri-Lopez JR; Colunga-Pedraza IJ; Guajardo-Jauregui N; Rodriguez-Romero AB; Lugo-Perez S; Cardenas-de la Garza JA; Arvizu-Rivera RI; Flores-Alvarado DE; Ilizaliturri-Guerra O; Garcia-Arellano G; Garza-Acosta AC
    Clin Rheumatol; 2022 May; 41(5):1413-1420. PubMed ID: 34826020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of subclinical atherosclerosis in psoriatic arthritis patients: a study based on carotid ultrasound.
    Ibáñez-Bosch R; Restrepo-Velez J; Medina-Malone M; Garrido-Courel L; Paniagua-Zudaire I; Loza-Cortina E
    Rheumatol Int; 2017 Jan; 37(1):107-112. PubMed ID: 27885376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis.
    Puig L
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Carotid Ultrasound and Systematic Coronary Risk Evaluation Charts for the Cardiovascular Risk Stratification of Patients with Psoriatic Arthritis.
    Martínez-Vidal MP; Andrés M; Jovaní V; Santos-Ramírez C; Romera C; Fernández-Carballido C
    J Rheumatol; 2020 May; 47(5):682-689. PubMed ID: 31203214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with high cardiovascular risk in psoriatic arthritis and non-psoriatic spondyloarthritis.
    Kavadichanda C; Shanoj KC; Ganapathy S; Shah SI; Ananthakrishnan R; Sahoo J; Negi VS
    Rheumatol Int; 2022 Feb; 42(2):251-260. PubMed ID: 35031846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the SCORE chart underestimating the real cardiovascular (CV) risk of patients with psoriatic arthritis? Prevalence of subclinical CV disease detected by carotid ultrasound.
    Martínez-Vidal MP; Fernández-Carballido C
    Joint Bone Spine; 2018 May; 85(3):327-332. PubMed ID: 28716557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular effects of Etanercept in patients with psoriatic arthritis: evidence from the cardiovascular risk in rheumatic diseases database.
    Di Minno MN; Iervolino S; Zincarelli C; Lupoli R; Ambrosino P; Pizzicato P; Di Minno A; Pappone N; Peluso R
    Expert Opin Drug Saf; 2015; 14(12):1905-13. PubMed ID: 26618553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriatic arthritis and nail changes: exploring the relationship.
    Sandre MK; Rohekar S
    Semin Arthritis Rheum; 2014 Oct; 44(2):162-9. PubMed ID: 24932889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.